Ascletis Pharma
CompanyChinaFounded 2014
Ascletis Pharma develops one asset, in phase 1 (ASC47 in chronic weight management). Mostly small molecule acting on lipid and ceramide metabolism; based in China, founded in 2014.
- 1
- Asset
- Furthest stage
- Phase 1
- 2
- Trials
- 0
- Signals
Pipeline
1Thyroid hormone receptor beta agonist under evaluation for metabolic disorders and weight management
Phase 1, Small molecule, Lipid and ceramide metabolism, chronic weight management
Full company profiles: pipeline, trials, funding and people.
In the full profile
- Evidence behind the mechanisms2
- Trials2
- Deals7
- Signals1
- Similar companies6